Retatrutide is an advanced synthetic tri-agonist researched for its interaction with GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors in experimental metabolic studies
Advantages of Semaglutide: Well-established safety and efficacy data from decades of diabetes use Approved dosing pathway: gradual titration from 0.25 mg reduces GI side effects Available at Hartwater Wellness as a cash-pay service with transparent monthly pricing Lower cost than tirzepatide at therapeutic doses Considerations: Modestly lower weight loss ceiling compared to tirzepatide Gastrointestinal side effects (nausea, vomiting, diarrhea) most common during titration Tirzepatide Tirzepatide is a dual GIP/GLP-1 receptor co-agonist
Semaglutide (Ozempic, Novo Nordisk, Bagsvrd, Denmark) and tirzepatide (Mounjaro, Eli Lilly and Company, Indianapolis, IN, USA) were used
Packer M
Their individual potential is staggering
Is research-grade Retatrutide legal to purchase in Canada